###### Strengths and limitations of this study

-   To the best of our knowledge, this is the first systematic review of the efficacy of diabetes management (multiple components) interventions focused on South Asian patients.

-   Evidence is stratified by location of study, thereby allowing the examination of chronic diabetes management interventions on South Asians living in India and immigrant South Asian patients living in Western countries.

-   Included a systematic review of yoga interventions for diabetes management in South Asian patients with diabetes.

-   Given the significant heterogeneity in interventions and outcome results, a pooled analysis was not possible.

-   Medication adherence was not addressed in almost all of the trials.

Introduction {#s1}
============

South Asian persons originating from Pakistan, Bangladesh or India experience a 50% higher risk of developing type 2 diabetes mellitus compared with other populations, irrespective of whether they live in South Asia or Western countries.[@R1] [@R2] This high global incidence of type 2 diabetes has significant ramifications on this population as type 2 diabetes is associated with a 2--4 times increased risk of myocardial infarction and stroke compared with those without diabetes. In Canada, age-adjusted standardised mortality is also three times higher in South Asian patients with diabetes compared with South Asian patients without diabetes.[@R1] Robust clinical trial evidence demonstrates that reducing glycated haemoglobin (HbA1c), blood pressure and fasting blood lipids, using lifestyle modification and diabetes treatment, reduces total mortality by 46%, cardiovascular death by 57% and non-fatal cardiovascular events by 59%.[@R3] [@R4] As such, multiple national guideline bodies and diabetes programmes recommend diabetes education and behaviour modification to promote diet, exercise and diabetes medication adherence to achieve these critical reductions in HbA1c, blood pressure and lipids.

Despite guidelines and diabetes programmes to improve diabetes management, diabetes control remains suboptimal in many populations including South Asians.[@R5] [@R6] A study in Canada reports that 55% of South Asian patients are above recommended HbA1c targets, 36% above blood pressure targets and 58% are above lipid-level targets for diabetes.[@R5] Further, South Asian patients are 24% less likely to achieve recommended targets for diabetes than the general population and also less likely to exercise or follow a healthy diet.[@R6] [@R7] This large gap in diabetes control in South Asians patients propelled the development of novel and culturally adapted diabetes management strategies in this group. Whether such strategies improve diabetes control in South Asian patients remains unclear. Therefore, we conducted a systematic review of all published randomised controlled trials (RCT) and prospective pre-post-test observational studies evaluating lifestyle or educational interventions compared with usual care or control in South Asian patients with type 2 diabetes on change in HbA1c. We also collected data on change in blood pressure, lipid levels, anthropometric measures and diabetes knowledge. We evaluated potential differences in change in HbA1c by intervention and region of study (South Asia vs Western countries).

Methods {#s2}
=======

The methods were in accordance with the PRISMA checklist for systematic reviews of intervention trials.

Data sources {#s2a}
------------

We performed a systematic review of intervention studies for type 2 diabetes management in South Asian patients. With the help of a medical librarian, we reviewed MEDLINE, EMBASE and CINAHL databases for articles published between 1 January 1990 and 1 February 2014. The search terms included India, Pakistan, Bangladesh, South Asian, East Indian, diabetes mellitus (type 2), manage, review, management, intervention, disease management, patient compliance, cultural characteristic, attitudes to health, cultural perception, outcomes, access to care and lifestyle changes (see online [supplementary file](#SM1){ref-type="supplementary-material"} for the full electronic search strategy). Searches were not limited by language. All articles were combined into a single list, and duplicates were excluded, resulting in 271 abstracts for review (see [figure 1](#BMJOPEN2015008986F1){ref-type="fig"}).
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Study selection {#s2b}
---------------

Two authors reviewed all abstracts (NB and JJ; see [figure 1](#BMJOPEN2015008986F1){ref-type="fig"}). Studies were included if they were: conducted with adult patients identified as South Asian (originating from India, Pakistan or Bangladesh); randomised control trials or pre-post study designs, included any educational or lifestyle intervention for type 2 diabetes management and if they reported on any one of the outcomes of interest: absolute changes in HbA1c (primary outcome of interest), fasting blood glucose, blood pressure, weight, body mass index (BMI), waist circumference (WC), lipid levels and knowledge. We excluded studies where participants were paediatric populations, or had gestational diabetes, prediabetes or type 1 diabetes. We also excluded reviews, cross-sectional, case--control, case series studies as well as drug efficacy studies (including complementary, eg, Ayurvedic medicines). We did not include studies from other South Asian countries as there was a significant paucity of studies in those groups.

Study quality {#s2c}
-------------

All full-text studies that met the selection criteria were evaluated for bias, and were appraised on the basis of a component approach from the Cochrane Review Groups and Jadad score for reporting RCTs.[@R8] [@R9] These methodological quality measures are listed in [table 3](#BMJOPEN2015008986TB3){ref-type="table"}. Given the nature of the interventions, blinding of participants and caregivers was not possible. We evaluated separately the subgroup of higher quality RCTs that specified appropriate methods or type of randomisation, described losses to follow-up and intention-to-treat analysis.

Data extraction {#s2d}
---------------

Data extraction was completed in duplicate (NB and JJ). Any discrepancies were discussed and consensus achieved (NB, JJ and NAK). Since the outcomes and interventions of the study were clinically heterogeneous, no quantitative data synthesis was performed. Systematic review of the studies was a priori stratified by study location (South Asian countries vs Western countries) as these healthcare delivery systems, and potentially patient populations, were expected to be significantly different. Interventions were also described by type: education, exercise, dietary or mixed studies (defined as a combination of at least two of the aforementioned intervention types). Change in HbA1c from baseline (delta HbA1c) was the primary outcome for this review and was reported, where data were available, as the difference in delta HbA1c between the intervention and control groups. Findings from duplicate publications were only included once.

Results {#s3}
=======

From a review of 274 articles, 23 studies (n=3613) were included in this final review ([figure 1](#BMJOPEN2015008986F1){ref-type="fig"} and [table 1](#BMJOPEN2015008986TB1){ref-type="table"}). Seven studies were conducted in Western countries (n=2532, all based in Europe)[@R10] and 16 studies were conducted in people living in South Asia (n=1081, all based in India (indigenous Indians)).[@R18] There were 15 RCTs (n=3279), with 9 (n=789) conducted in India.

###### 

Study characteristics by region

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                                                           Country                           Sample size   Design        Follow-up\   Intervention type\                                                                                 Intervention
                                                                                                                                                (months)     /control group                                                                                     
  ------------------------------------------------------------------------------- --------------------------------- ------------- ------------- ------------ -------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Diabetes management trials in Europe*                                                                                                                                                                                                                        

  Mixed trials                                                                                                                                                                                                                                                  

   O\'Hare *et al*[@R10]                                                          UK (England)                      361           Cluster RCT   12           Mixed/usual care                                                                                   SA link workers, additional DSME from nurse

   Bellary *et al*[@R11]                                                          UK (England)                      1486          Cluster RCT   24           Mixed/usual care                                                                                   SA link workers, additional DSME from nurse

   Choudhury *et al*[@R14]                                                        UK (Wales)                        42            Pre-post      1            Mixed/no control                                                                                   Culturally adapted X-PERT programme

   Vyas *et al*[@R16]                                                             UK (England)                      211           Cluster RCT   12           Mixed/usual care                                                                                   Diabetes nurse, dietician and chiropodist advice

  Education trials                                                                                                                                                                                                                                              

   Hawthorne and Tomlimson[@R12]                                                  UK (England)                      201           RCT           6            Education/usual care                                                                               Picture flashcards and structured education package delivered by link worker

   Hawthorne[@R13] (duplicate)                                                    UK (England)                      199           RCT           6            Education/usual care                                                                               Picture flashcards delivered by link worker (not trained in psychology)

   Baradaran *et al*[@R15]                                                        UK (Scotland)                     118           RCT           6            Education/usual care                                                                               Cultural-specific education by dietician and podiatrist, didactic and interactive group session, visual aids

   Middelkoop *et al*[@R17]                                                       The Netherlands (South Holland)   113           RCT           6            Education/patients who received educational materials only at the end of the study                 Culture-specific education materials: general diabetes information in Surinam-Hindi language and nutrition information specific to South Asian cooking---by specialist diabetes nurse and dietician

  *Diabetes management trials in India*                                                                                                                                                                                                                         

  Mixed trials                                                                                                                                                                                                                                                  

   Balagopal *et al*[@R18]                                                        India (Tamil Nadu)                30            Pre-post      7            Mixed/no control                                                                                   Culturally and linguistically appropriate education on dietary modifications, improving physical activity and reducing stress provided by trained trainers; and education on blood glucose management by a DE

   Balagopal *et al*[@R19]                                                        India (Gujarat)                   118           Pre-post      6            Mixed/no control                                                                                   Culturally and linguistically appropriate health education on dietary modifications, improving physical activity and risk for developing diabetes by CHW; education and counselling by DE. peer based; CHW; group sessions; advice on exercise and diet; Meditation, problem-solving

   DeSouza and Subrahmanya Nairy,[@R26] DeSouza and Nairy[@R27]                   India (Goa)                       60            Pre-post      2            Mixed/usual care                                                                                   Nurse-directed intervention (education, psychosocial support, visual aids)

  Exercise-based trials                                                                                                                                                                                                                                         

   Hameed *et al*[@R24]                                                           India (Delhi)                     48            RCT           2            Exercise/group on stationary cycling programme without work load and static stretching exercises   Progressive Resistance Training Program (2--3×/week)

   Misra *et al*[@R25]                                                            India (Delhi)                     30            Pre-post      3            Exercise/no control group                                                                          Progressive Resistance Training Program (3×/week)

   Shenoy *et al*,[@R30] Arora *et al*[@R31]                                      India (Punjab)                    30            RCT           4            Exercise/participants underwent no training but continued medications                              Progressive resistance training (2 times per weeks) and aerobic exercise (3 times a week)

   Shenoy *et al*[@R32]                                                           India (Punjab)                    40            RCT           2            Exercise/participants underwent no training but continued medications                              Aerobic walk using a heart rate monitor and pedometer to achieve a target of 150 min per week

  Yoga-based trials: asanas (body postures) and pranayama (breathing exercises)                                                                                                                                                                                 

   Shantakumari *et al*[@R20]                                                     India (Kerala)                    100           RCT           3            Exercise/patients on OHA without yogic exercises                                                   OHA and yoga exercises (asanas and pranayama meditation techniques)

   Vaishali *et al*[@R21]                                                         India (Karnataka)                 57            RCT           3            Exercise/received general healthy lifestyle and exercise information                               Yogic exercises (asanas) and specially developed breathing techniques (pranayama)

   Singh *et al*[@R34]                                                            India (Delhi)                     24            Pre-post      1.3          Exercise                                                                                           Yoga asanas

   Madanmohan *et al*[@R35]                                                       India (Tamil Nadu)                15            Pre-post      1.5          Exercise                                                                                           Yoga (asanas and pranayama) including yogic counselling and lifestyle modification advice

  Education trials                                                                                                                                                                                                                                              

   Adepu *et al*[@R22]                                                            India (Kerala)                    70            RCT           4            Education/pharmacist counselling at study end                                                      Patient counselling by pharmacist

   Ghosh *et al*[@R23]                                                            India (Uttar Pradesh)             22            RCT           1.5          Education/pharmacist counselling and information leaflets at study end                             Counselling by pharmacist, information leaflets

   Malathy *et al*[@R29]                                                          India (Tamil Nadu)                207           RCT           3            Education/patients received counselling and information leaflets at study end                      Pharmacist counselling and information leaflets

   Shetty *et al*[@R33]                                                           India (Tamil Nadu)                215           RCT           12           Education/usual care                                                                               SMS messaging on cell phones on diabetes management education

  Diet-based trials                                                                                                                                                                                                                                             

   Pande *et al*[@R28]                                                            India (Maharashtra)               15            Pre-post      1            Diet/no control                                                                                    Low and low-medium glycaemic load meals
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Intervention type: education, exercise, dietary or mixed (two or more intervention types).

CBA, controlled before and after experiment; CHW, community health worker; DE, diabetes educator; DSME, diabetes self-management education; OHA, oral hypoglycaemic agent; RCT, randomised controlled trial; SA, South Asian.

Patient characteristics {#s3a}
-----------------------

The average age of patients in the studies ranged from 35 to 66 years with the studies from India more often including younger patients ([table 2](#BMJOPEN2015008986TB2){ref-type="table"}). While approximately half of the patients enrolled in the European-based studies were women, the majority of participants in the India-based studies were men. Mean HbA1c levels at baseline were ≥61 mmol/mol (7.7%) and were generally similar between study regions.

###### 

Patient characteristics in the studies by region

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study author, year                       Study population                    Recruitment site                                                                  Age\         Women\   HbA1c\      BMI\                    SBP\                      DBP mm Hg\
                                                                                                                                                                 Years\       (%)      mmol/mol\   kg/m^2^ mean            mm Hg\                    mean
                                                                                                                                                                 mean                  (%)                                 mean                      
  ---------------------------------------- ----------------------------------- --------------------------------------------------------------------------------- ------------ -------- ----------- ----------------------- ------------------------- ------------------------
  *Diabetes management trials in Europe*                                                                                                                                                                                                             

  Mixed trials                                                                                                                                                                                                                                       

   O\'Hare, 2004                           Indian, Pakistani and Bangladeshi   GP practices                                                                      58.9         49       64 (8.0)                            145                       81

   Bellary and O\'Hare, 2008               Indian, Pakistani and Bangladeshi   Inner city GP practices                                                           57.0         48       63 (7.9)    28.5                    140                       83

   Choudhury, 2008                         Bangladeshi                         Urban community                                                                                67                                                                     

   Vyas, 2003                              Pakistani                           GP offices                                                                                     46                                                                     

  Education trials                                                                                                                                                                                                                                   

   Hawthorne, 1997                         Pakistani                           Manchester Diabetes Centre and 10 GP practices                                    53           53       70 (8.5)                                                      

   Hawthorne, 2001                         Pakistani                           Manchester Diabetes Centre or diabetes mini clinics                               53.2         53       68 (8.4)                                                      

   Baradaran, 2006                         Indian and Pakistani                Daycare centres and GP offices                                                    58.4         49                                                                     

   Middelkoop, 2001                        South Asian Surinamese              GP practice and outpatient clinics                                                53.3         50       67 (8.3)                                                      

  *Diabetes management trials in India*                                                                                                                                                                                                              

  Mixed trials                                                                                                                                                                                                                                       

   Balagopal, 2008                         Indian                              Rural community                                                                   35.8         59                   23.3                    133                       93

   Balagopal, 2012                         Indian                              Rural community                                                                   41.9         53                   24.4                    151                       89

   DeSouza, 2003, 2004                     Indian                              Outpatient clinic, private hospitals                                              41.0--60.0   28                   Obese I: 20%\           \<140 I: 93.3% C: 86.7%   
                                                                                                                                                                                                   C: 6.7%                                           

  Exercise-based trials                                                                                                                                                                                                                              

   Hameed, 2012                            Indian                              University hospital outpatient clinics                                            44.7         27       68 (8.4)    27.3                    130                       79

   Misra, 2008                             Indian                              Outpatient and diabetes clinic                                                    40.8         27       61 (7.7)    24.1                                              

   Shenoy, 2009                            Indian                              University health centre                                                          53.4         47       62 (7.8)                                                      

   Shenoy, 2010                            Indian                              Outpatients                                                                       52           28       57 (7.4)    27                      127                       86

  Yoga-based trials                                                                                                                                                                                                                                  

   Shantakumari, 2013                      South Asian                         Outpatient department of holistic medicine and university-based diabetes clinic   45.0         49                   23.1                                              

   Vaishali, 2012                          South Asian                         Diabetes clinic                                                                   65.8         37       91 (10.5)   27.6                                              

   Singh, 2004                             Indian                              Not specified                                                                     30--60                75 (9.0)                            142                       86.7

   Madanmohan, 2012                        Indian                              University hospital                                                               50.4         100                                                                    

  Education-based trials                                                                                                                                                                                                                             

   Adepu, 2007                             South Asian                         Urban community pharmacies                                                        52.6         31                                                                     

   Ghosh, 2010                             South Asian                         Urban hospital outpatient                                                         \>50.0       28                                                                     

   Malathy, 2011                           Indian                              Urban pharmacies                                                                  52.0         59       66 (8.2)    Obese I: 22.6% C: 20%   \>140\                    \>90 I: 26.3% C: 25.8%
                                                                                                                                                                                                                           I: 15.3% C: 17.1%         

   Shetty, 2011                            Indian                              Outpatients                                                                       50.2                  75 (9.0)    27.4                    \>140/90\                 
                                                                                                                                                                                                                           I: 42.7%\                 
                                                                                                                                                                                                                           C: 41%                    

  Diet-based interventions                                                                                                                                                                                                                           

   Pande, 2012                             Indian                              Medical College and General Hospital, diabetes outpatient department              50.0         40       64 (8.0)    18.0--26.0                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BMI, body mass index; C, control group; DBP, diastolic blood pressure; GP, general practitioner; HbA1c, glycated haemoglobin; I, intervention group; SBP, systolic blood pressure.

Data quality {#s3b}
------------

Overall, the data quality was modest ([table 3](#BMJOPEN2015008986TB3){ref-type="table"}). There were five RCTs conducted in India (total n=390) and four RCTs conducted in Europe (total n=2161) that measured HbA1c. Only three of the RCTs reported on either type or method of randomisation and quantified loss to follow-up less than 20%,[@R11] [@R12] [@R21] and only two trials included information on allocation concealment.[@R12] [@R21] Additionally, none of the studies reported on blinding in outcome assessment. Fourteen studies reported loss to follow-up, and two studies had losses greater than 20%.[@R15] [@R16] Only nine studies analysed reported using intention to treat.

###### 

Quality appraisal of trials

  Author, year          Randomised                  Randomisation method   Type of randomisation   Allocation concealment    Blinding   Per cent Lost to follow-up    ITT
  --------------------- --------------------------- ---------------------- ----------------------- ------------------------- ---------- ----------------------------- -----
  Middelkoop            RCT                         Date of birth          NS                      NS                        None       NS                            NS
  Shenoy, 2009          RCT                         NS                     NS                      NS                        None       3                             NS
  Shenoy, 2010          RCT                         NS                     NS                      NS                        None       NS                            Yes
  Shantakumari          Randomised parallel study   NS                     NS                      NS                        None       NS                            NS
  Vaishali              RCT                         NS                     Block                   Sealed opaque envelopes   None       5.3                           NS
  Hawthorne             RCT                         Random number tables   NS                      Sealed envelopes          None       6.5                           No
  Adepu                 RCT                         NS                     NS                      NS                        None       14.3                          No
  Baradaran             RCT                         NS                     Minimisation            NS                        None       37.3                          No
  Ghosh                 RCT                         NS                     NS                      NS                        None       Yes                           NS
  Malathy               RCT                         NS                     NS                      NS                        None       None                          Yes
  Hameed                RCT                         Random number tables   NS                      NS                        None       Yes                           Yes
  Shetty                RCT                         Random number tables   NS                      NS                        None       NS                            No
  O'Hare                Cluster RCT                 None                   NS                      NS                        None       10.0                          No
  Bellary               Cluster RCT                 Simple                 Simple                  NS                        NS         10.8                          Yes
  Vyas                  Cluster RCT                 NS                     By GP practice[@R4]     NS                        NS         44                            No
  DeSouza, 2003, 2004   Pretest post-test           Convenience sampling   NA                      NA                        None       NS                            Yes
  Balagopal, 2008       Pretest post-test           NA                     NA                      NA                        None       Yes: refusals                 Yes
  Balagopal, 2012       Pretest post-test           NA                     NA                      NA                        None       Yes: migration and refusals   Yes
  Mirsa                 Pretest post-test           NA                     NA                      NA                        None       NS                            Yes
  Choudhury             Pretest post-test           NA                     NA                      NA                        None       8.9                           No
  Pande                 Pretest post-test           NA                     NA                      NA                        None       NS                            NS
  Singh                 Pretest post-test           NA                     NA                      NA                        NS         NS                            NS
  Madanmohan, 2012      Pretest post-test           NA                     NA                      NA                        NS         \<1                           Yes

ITT, intention-to-treat; NA, not applicable; NS, not specified; RCT, randomised controlled trial.

Interventions {#s3c}
-------------

There were seven studies of mixed interventions (three from India, four from Europe), eight educational interventions (four from India and three from Europe), four exercise intervention studies (all from India), four yoga intervention studies (all from India) and one study with a diet-based intervention (from India; [table 1](#BMJOPEN2015008986TB1){ref-type="table"}).

Interventions from studies of South Asians living in Europe {#s3d}
-----------------------------------------------------------

Intervention studies with South Asians living in Europe were either mixed interventions or education based. Common features of these interventions included enhanced diabetes education that was culturally specific, the use of bilingual link workers (community members and/or healthcare professionals including nurses or dieticians), as well as the use of written materials and visual aids. Link workers assisted patients with language translation, encouraged patient attendance at clinics, and helped organise educational sessions. One study[@R15] included a dietician and podiatrist to provide education using didactic and interactive sessions with visual aids. The other[@R14] used peer educators trained by a general practitioner with a special interest in diabetes to provide educational sessions giving advice on exercise, diet, attending appointments, cultural behaviours and the development of diabetes.

Interventions from studies of indigenous Indians {#s3e}
------------------------------------------------

Studies with indigenous Indians included mixed interventions, exercise, yoga and educational interventions. Common features of these interventions included resistance exercise, and the use of community-based peers and healthcare professionals (pharmacists, nurses) as well as culture-specific dietary education. Three of the four yoga interventions included both asanas (static yoga positions) and pranayama (breathing exercises) and one only included asanas alone.[@R20] [@R21] [@R34] [@R35] Three exercise studies[@R24] [@R25] [@R30] used resistance training, while one study included aerobic exercise.[@R30] [@R31] The other mixed intervention study from Balagopal *et al*[@R18] featured education and experiential training on meditation/relaxation techniques, cooking (through demonstrations, recipe competitions and model meals) and exercise (through demonstrations, competitive fun events and dance-based exercise).

Change in HbA1c {#s3f}
---------------

Twelve studies reported HbA1c, while six additional studies included other measures of glycaemia ([table 4](#BMJOPEN2015008986TB4){ref-type="table"}). Among RCTs conducted in India (5 trials; n=390), four studies demonstrated significant reductions in HbA1c in the intervention group compared with usual care (yoga and exercise interventions). The yoga interventions were also significant in Northern and Southern India. All exercise interventions were conducted in Northern India, so regional differences could not be ascertained. Among the four RCTs conducted in Europe (n=2161), only one study of an education intervention in 113 patients reported a significant reduction in HbA1c with the intervention,[@R17] whereas the remainder found no significant change (mixed and education interventions). Overall, the interventions associated with significant reductions in HbA1c tended to be based in India, exercise or yoga focused, while the interventions associated with no significant improvement in HbA1c tended to be among the larger trials, South Asian patients living in Europe and focused on enhanced education.

###### 

Outcomes of diabetes intervention studies\*

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                     HbA1c\                                            BG (mmol/L)                                       SBP (mmHg)                                       DBP (mmHg)                                        Lipids\                      Anthropometrics
                                            mmol/mol (%)                                                                                                                                                                                           (mmol/L)                     
  ----------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------ ------------------------------------------------- ---------------------------- -----------------------------------------------
  Mixed trials in Europe                                                                                                                                                                                                                                                        

   O\'Hare *et al*[@R10]                    −23 (−0.0) (p=0.87)                                                                                 −4.6 (p=0.035)                                   −3.4 (p=0.003)                                    TC: −0.38 (p=0.005)          

   Bellary *et al*[@R11]                    −22 (−0.2) (p=0.11)                                                                                 −0.33 (p=0.76)                                   −1.91 (p\<0.001)                                  TC: +0.03 (p=0.37)           BMI: +0.40 (p\<0.001)\
                                                                                                                                                                                                                                                                                WC: −0.2 (p=0.67)

  Mixed trials in India                                                                                                                                                                                                                                                         

   Balagopal *et al*[@R18]                                                                    FBG:\                                             −3.2 (p=0.48)                                    −5.5 (p=0.134)                                                                 BMI: +0.2 (p=0.63)\
                                                                                              −3.34 (p=0.03)                                                                                                                                                                    WC: −4.8 cm (p=0.04)

   Balagopal *et al*[@R19]                                                                    FBG:\                                             I −6.2 (p\<0.001)                                I −0.17 (p\<0.001)                                                             BMI: I −1.02 (p\<0.001)\
                                                                                              I −1.06 (p\<0.001)                                                                                                                                                                WC: I −3.94 cm (p=0.001)

  Exercise-based trials in India                                                                                                                                                                                                                                                

   Hameed *et al*[@R24]                     −17 (−0.6) (p\<0.001)                                                                               −4.79 (p=0.07)                                   −1.91 (p=0.28)                                    TC: −0.07 (p=0.53)\          Weight −0.31 (p=0.36)\
                                                                                                                                                                                                                                                   TG: −0.06 (p=0.56)\          WC (cm): −2.04 (p=0.008)
                                                                                                                                                                                                                                                   HDL-C:+0.15 (p=0.004)\       
                                                                                                                                                                                                                                                   LDL-C: −0.19 (p=0.10)        

   Misra *et al*[@R25]                      I −18 (−0.5) (p\<0.001)                           FBG:\                                                                                                                                                I: TC: −0.39 (p=0.003)\      I: BMI: +0.1 (p=0.614)\
                                                                                              I −2.7 (p\<0.001)                                                                                                                                    TG: −0.39 (p\<0.001)\        WC: −1.6 (p\<0.001)
                                                                                                                                                                                                                                                   HDL:+0.02 (p=0.33)\          
                                                                                                                                                                                                                                                   LDL: −0.09 (p=0.21)          

   Shenoy *et al*[@R30]                     PRT: −3 (−1.8) (p=0.002)\                         PRT: −3.83 (p=0.021)\                             PRT: −9 (p=0.001)\                               PRT: −8 (p=0.001)\                                                             
                                            AE: −9 (−1.3) (p=0.002) C: −21 (−0.21) (p=NS)     AE: −1.44 (p=0.021)\                              AE: −3 (p=NS)\                                   AE: −1 (p=NS)\                                                                 
                                                                                              C: −1.66 (p=NS)                                   C: +2 (p=NS)                                     C: +1 (p=NS)                                                                   

   Shenoy *et al*[@R32]                     I: −15 (−0.8) (p=0.0001)\                         FBG\                                              I: +1.5 (p=0.868)\                               I: −10.8 (p=0.010)\                                                            BMI: I: −1.1 (p=0.0001)\
                                            C: −23 (−0.1)\                                    I: −4.24 (p=0.0001)\                              C: −3.3 (p=0.133)\                               C: −3.7 (p=0.0058)\                                                            C: +0.6 (p=0.0001)\
                                            (p=0.242)\                                        C: −0.12 (p=0.0007)\                              Difference in post-test I and C scores p=0.019   Difference in post-test I and C scores p=0.0001                                Difference in post-test I and C scores p=0.56
                                            Difference in post-test I and C scores p=0.0023   Difference in post-test I and C scores p=0.0001                                                                                                                                   

  Yoga-based interventions in India                                                                                                                                                                                                                                             

   Vaishali *et al*[@R21]                   −15 (−0.8) (p\<0.001)                             FBG:\                                                                                                                                                TC: −0.48 (p\<0.001)\        
                                                                                              −1.58 (p\<0.001)                                                                                                                                     TG: −0.25 (p\<0.001)\        
                                                                                                                                                                                                                                                   HDL:+0.13 (p\<0.001)\        
                                                                                                                                                                                                                                                   LDL: −0.18 (p\<0.05)         

   Singh *et al*[@R34]                      −10 (−1.2) p=0.035                                FBG:\                                             −16 p=0.001                                      −8.8 p=0.001                                                                   
                                                                                              −2.7 p\<0.001                                                                                                                                                                     

   Madanmohan *et al*[@R35]                                                                   FBG:\                                                                                                                                                TC: −0.13 p=0.01\            
                                                                                              −1.1 p=0.004                                                                                                                                         LDL −0.28 p=0.001\           
                                                                                                                                                                                                                                                   HDL −0.45 p=0.02             

   Shantakumari *et al*[@R20]                                                                                                                                                                                                                      TC: I −0.65 (p\<0.01)\       Weight: I −2.6 (p\<0.05)\
                                                                                                                                                                                                                                                   C+0.25 (p=NS)\               C+0.86 (p\<0.05)\
                                                                                                                                                                                                                                                   TG: I −0.25 (p\<0.05);\      BMI: I −1.53 (p=NS)\
                                                                                                                                                                                                                                                   C +0.28 (p=NS)\              C+0.3 (p=NS)
                                                                                                                                                                                                                                                   LDL-C: I −0.63 (p\<0.01);\   
                                                                                                                                                                                                                                                   C +0.01 (p=NS)\              
                                                                                                                                                                                                                                                   HDL-C: I+0.07 (p=NS);\       
                                                                                                                                                                                                                                                   C −0.03 (p=NS)               

  Education-based interventions in Europe                                                                                                                                                                                                                                       

   Hawthorne and Tomlimson[@R12]            I −20 (−0.3) (p=NS)                                                                                                                                                                                    I: TC 0.04                   

   Hawthorne[@R13]                          −20 (−0.4) (p=NS)                                                                                                                                                                                                                   

   Middelkoop *et al*[@R17]                 −19 (−0.4) (p=0.02)                                                                                                                                                                                                                 

  Education-based interventions in India                                                                                                                                                                                                                                        

   Shetty *et al*[@R33]                     NS difference in mean HbA1c\                      FBG: I −1.1                                                                                                                                          TC: I: −0.4 p\<0.03\         
                                            \<64 (8%)\                                                                                                                                                                                             C: −0.3 p\<0.03              
                                            I:+16.7%\                                                                                                                                                                                                                           
                                            C:+24.3%                                                                                                                                                                                                                            

   Adepu *et al*[@R22]                                                                        Capillary BG:\                                                                                                                                                                    
                                                                                              I: −3.12, (p\<0.001)\                                                                                                                                                             
                                                                                              C: −0.14\                                                                                                                                                                         
                                                                                              (p=NS)                                                                                                                                                                            

   Gosh *et al*[@R23]                                                                         FBG:\                                                                                                                                                                             
                                                                                              −0.83 (p\<0.05)\                                                                                                                                                                  
                                                                                              Postprandial G\                                                                                                                                                                   
                                                                                              −1.94 (p\<0.01)                                                                                                                                                                   

   Malathy *et al*[@R29]                                                                      Postprandial glucose:\                                                                                                                               TC: I −0.53 (p\<0.001)\      
                                                                                              I −1.81\                                                                                                                                             C −0.29 (p\<0.05)\           
                                                                                              C −0.99 (p\<0.001)                                                                                                                                   LDL: I −0.52 (p\<0.001)\     
                                                                                                                                                                                                                                                   C −0.29 (p\<0.01)\           
                                                                                                                                                                                                                                                   HDL: I+0.04 (p\<0.05)\       
                                                                                                                                                                                                                                                   C+0.02 (p=NS)\               
                                                                                                                                                                                                                                                   TG I −0.12 (p\<0.001)\       
                                                                                                                                                                                                                                                   C −0.08 (p=NS)               

  Diet-based interventions India                                                                                                                                                                                                                                                

   Pande, 2012                              I −14 (−0.9)\                                     FBG:\                                                                                                                                                I TG −0.90 (p\<0.001)\       
                                            (p\<0.001)                                        I −1.99\                                                                                                                                             TC −1.01 (p\<0.001)\         
                                                                                              (p\<0.001)                                                                                                                                           HDL+0.18 (p=0.003)\          
                                                                                                                                                                                                                                                   LDL −0.67 (p=0.009)          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Note that 4 of the studies (Baradaran, Choudhury, Vyas and DeSouza) only included knowledge outcomes and thus were not included in this table (see ([table 5](#BMJOPEN2015008986TB5){ref-type="table"})).

The numbers represent the difference in change in parameters between the intervention and control groups if not otherwise stated.

AE, aerobic exercise; BG, blood glucose; BMI, body mass index; C, control group; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; I, intervention group; LDL-C, low-density lipoprotein cholesterol; NS, not significant; PRT, progressive resistance training group; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; WC, waist circumference.

Other end points {#s3g}
----------------

Eight studies reported blood pressure end points; and in four of the five RCT\'s reporting blood pressure outcomes, interventions were associated with reduced mean systolic (range −0.33 to −9 mm Hg) or diastolic blood pressure (range −1.91 to −10.8 mm Hg) compared with usual care. Of the two studies conducted in Europe, both reported significant reductions in either systolic or diastolic blood pressure. Of the six studies of indigenous Indians, four reported significant reductions in blood pressure. Mixed and exercise interventions were associated with blood pressure reduction. None of the education or dietary intervention studies evaluated blood pressure (all conducted in India). Eleven studies evaluated lipid levels with 10 intervention studies demonstrating significant reductions in at least one measured lipid level across all the intervention types ([table 4](#BMJOPEN2015008986TB4){ref-type="table"}) with two of three studies from Europe and the other eight from India reporting significant reductions. Six studies among indigenous Indians included BMI or weight measurement with three studies reporting significant reductions (pretest post-test mixed intervention, one yoga and one exercise-based RCT),[@R19] [@R32] whereas three others reported no significant reduction or weight increases. All four studies conducted in India that measured WC found significant reductions with the intervention. One European mixed trial measured BMI and WC and identified a significant increase in BMI with the intervention.

Ten studies reported the effect of educational and mixed interventions on knowledge of diabetes, its prevention, management and complications and/or on quality of life ([table 5](#BMJOPEN2015008986TB5){ref-type="table"}). Among indigenous Indians, the majority of studies targeting diabetes knowledge and related practices as well as patients\' quality of life through educational interventions reported significant improvement in the targeted outcomes. Among education studies conducted in Europe targeting knowledge of and practices related to diabetes, education intervention was not consistently associated with the improvement of the outcomes. Specifically, while half of the studies reported an improvement in knowledge of and attitudes and behaviours related to diabetes, the other half either found no such improvement[@R14] or the difference in mean change scores between the intervention and control groups did not differ.[@R15] Improvement in knowledge was observed in men and women and across literacy levels in one study.[@R13]

###### 

Change in knowledge of diabetes, its prevention, management and complications and on quality of life

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                                           Intervention   Knowledge of diabetes, its prevention, management and complications and patients' quality of life
  --------------------------------------------------------------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Studies based in Europe                                                        

   Hawthorne and Tomlimson[@R12]                                  Education      Change in per cent of patients correctly answering questions about Knowledge: importance of diet (I +20%, C +6%), food group value scores (I +14%, C 1.5%), individual food value scores (I +13%, C +3.2%; adjusted difference for I is +7.8%), can manage hyperglycaemia (I +64%, C +12%), knowledge about the purpose of screening (I +48%, C baseline data missing to calculate per cent change), knowledge about diabetes complications (I +60%, C +1%) and knowledge about the role of the chiropodist (I +35%, C baseline data missing to calculate per cent change)Attitudes and behaviours: choosing correct food at wedding (I +14%, C −1.9%), glucose monitoring (I +29%, C 0%), number of people checking glucose more than once a week (I +33%, C baseline data missing to calculate per cent change), and keeping records of glucose levels (I +32%, C −7%); however, an attitude that is hard to refuse food at social events did not change after the intervention (I +10%, C +5%)

   Hawthorne[@R13]                                                Education      Change in scores or per cent of patients correctly answering questions related to diabetes in M and W: food knowledge scores (I: M +11%, W +14%; C: M +3%, W +4%), knowledge of eye (I: M +55%, W +63%; C: M −3%, W +4%), heart (I: M +32%, W +54%; C: M −3%, W −3%) and feet diabetes complications (I: M +47%, W +67%; C: M +9%, W +17%), knowledge of chiropody (I: M +42%, W +32%; C: M +10%, W −5%), can manage hyperglycaemia (I: M +68%, W +63%; C: M +9%, W +13%), know why to control glucose (I: M +60%, W +61%; C: M +3%, W 0%), know purpose of annual reviews (I: M +66%, W +33%; C: M +14%, W −7%), check glucose regularly (I: M +27%, W +40%; C: M −29%, W 0%) and keep glucose records (I: M +36%, W +28%; C: M −8%, W −4%)Change in scores or per cent of patients correctly answering questions related to diabetes in LW and IW: food knowledge scores (LW +12%, IW +6%), knowledge of eye (LW +59%, IW +30%), heart (LW +53%, IW +50%), and feet (LW +40%, IW +45%), diabetes complications, knowledge of chiropody (LW +42%, IW +25%), can manage hyperglycaemia (LW +53%, IW +55%), know why to control glucose (LW +71%, IW +42%), know purpose of annual checks (LW +44%, IW +42%), check glucose regularly (LW +20%, IW +17%)

   Choudhury *et al*[@R14]                                        Education      There was no significant change in days study participants adhered to general and specific diet, recommended exercise or foot care (SDSCA Questionnaire); no control group available.

   Baradaran *et al*[@R15]                                        Education      Difference in mean change in scores between I and C groups for knowledge 1.25 (p=0.27); attitude towards seriousness −0.17 (p=0.76); attitude towards complications 0.68 (p=0.38) and practice 0.76 (p=0.23).Per cent improvement in mean scores for knowledge (I intervention, EC, WC) about diabetes (I +12.5% (p=0.04); EC +5% (p=0.53); WC +12.2% (p=0.19), attitudes towards seriousness of diabetes (I +13.5% (p=0.005); EC +16.3% (p=0.001); WC +12.4% (p=0.04)), attitudes towards diabetes complications (I +8.1% (p=0.05); EC +1.5% (p=0.40); WC +6% (p=0.19)), and practice related to diabetes (I +20% (p=0.005); EC +1.7% (p=0.63); WC +25% (p=0.007))

   Vyas *et al*[@R16]                                             Mixed          Knowledge awareness and self-management questionnaires validated by Hawthorne. I: 0.09 knowledge; −0.15 self-management; C: 0.02 knowledge; 0.29 self-management (differences in prescores and postscores in the I and C groups)\
                                                                                 NS difference between intervention and control

  Studies based in India                                                         

   Balagopal *et al*[@R18]                                        Mixed          Knowledge score: +0.94 (p=0.085)

   Balagopal *et al*[@R19]                                        Mixed          Diabetes knowledge score (American Diabetes Association risk test): +0.47 (p\<0.001)

   Adepu *et al*[@R22]                                            Education      Change in per cent of patients correctly answering questions about knowledge of diabetes definition (I +22, C no change), causes of diabetes (I +67, C −2), methods of glucose measurement (I +43, C +4), diabetes complications (kidney (I +43, C no change), eye (I +27, C −3), frequency of eye examinations (I +67, C no change)), relationship between blood pressure and kidney functioning (I +60, C +3), frequency of blood pressure measurement in patients with diabetes (I +46, C +3), role of weight reduction in diabetes (I +47, C no change), hypoglycaemia (I +39, C +2) and its prevention/management (I +44, C −3)

   DeSouza and Subrahmanya Nairy,[@R26] DeSouza and Nairy[@R27]   Education      2003; Quality of life scores (difference in prescores and postscores for I and C groups):\
                                                                                 Total quality of life I +6.50, C +0.99 (p\<0.05); health and functioning domain I +7.18, C +0.93 (p\<0.05); social-economic domain I +5.81, C +0.61 (p\<0.05); psychological-spiritual I +0.81, C +0.15 (p=NS); family domain I +4.17, C +1.45 (p\<0.05)2004---Health-promoting behaviours scores (difference between postscores and pretest scores in the I and C groups and p value depicting the difference in post-test scores between the I and C groups): total health-promoting behaviour score: I +33.93, C 2.00 (p\<0.001); health and functioning domain I +30.33, C +3.93 (p\<0.001); social-economic domain I 3.07, C −0.46 (p\<0.001); psychological-spiritual domain I +3.87, C −1.47 (p\<0.001); family domain I +2.47, C −0.94 (p\<0.001)

   Malathy *et al*[@R29]                                          Education      KAP scores (differences in pre-KAP and post-KAP scores in the I and C groups)\
                                                                                 Knowledge: I +3.12 (p=0.0001); C −0.06 (p=NS)\
                                                                                 Attitude: I +0.92 (p=0.0001); C +0.06 (p=NS)\
                                                                                 Practice: I +0.08 (p=0.06); C no change (p=NS)\
                                                                                 Overall: I +4 (p=0.0001); C+0.4 (p=NS)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

C, control group; EC, ethnic control; I, intervention group; IW, illiterate women; KAP, knowledge, attitude and practice; LW, literate women; NS, not significant; M, men; W, women; WC, white control.

Higher quality randomised studies {#s3h}
---------------------------------

There were three randomised studies with a lower risk of bias[@R11] [@R21] (two mixed intervention RCTs conducted in Europe and one yoga-based trial conducted in India). Studies by Bellary *et al*[@R11] and Hawthorne[@R12] and Hawthorne and Tomlimson,[@R13] conducted in Europe (total n=1687), used bilingual, bicultural enhanced diabetes education, link workers and visual aids, and they found no significant improvement in HbA1c level with these interventions compared with usual control. In contrast, in the exercise intervention study based in India (n=57) and led by Vaishali *et al*,[@R21] there was a significant reduction in HbA1c levels among patients who underwent the intervention compared with their counterparts who did not undergo the exercise intervention.

Discussion {#s4}
==========

From the present review, diabetes management interventions targeted at South Asian patients were heterogeneous, yielding variable and limited success in HbA1c reduction. Changes in HbA1c level differed by region and intervention, whereby studies based in India that included exercise or yoga interventions were most successful in reducing HbA1c among individuals with type 2 diabetes. Blood pressure, lipid levels and knowledge were generally improved with various diabetes interventions compared with usual care in European-based and Indian-based studies, whereas BMI did not generally change with the interventions across studies.

The observation that HbA1c reduction was variable and limited across trials in Europe poses a stark contrast to the findings of culturally adapted diabetes management trials targeted at other ethnic groups studied in the Western world.[@R36] Meta-analyses of RCTs ascertained that culturally adapted diabetes management programmes are superior to non-culturally adapted programmes with significant improvements (−17 mmol/mol (−0.6%)) in HbA1c at 6 months and knowledge scores.[@R36] Cultural adaptation processes aim to adapt interventions or messages using culture to the intended audience. However, these meta-analyses included largely African-American or Hispanic ethnic groups. Interventions that were face to face, incorporated a peer educator and cognitive reframing techniques were found to be associated with reductions in HbA1c compared with usual care in African-American or Hispanic populations.[@R39] In a culturally adapted diabetes programme targeted to a Latin American population, the intervention consisted of use of culturally tailored education, exercise (Latin dance) and dietary change compared with usual care. The cultural adaptations included family involvement, foods common in Latin American countries that could be used in modified Mediterranean diet recipes; and it also incorporated Latin music, language and symbols in meetings and materials.[@R40] The intervention group significantly reduced HbA1c (−19 mmol/mol (−0.4%)) at 6 months compared with the usual care group.

Many of the aforementioned culturally adapted techniques were incorporated in the interventions targeted at South Asian patients with type 2 diabetes described in this review paper; however, reduction in HbA1c levels was not consistent across studies. We can speculate that the success of the trials from the meta-analysis in reducing HbA1c may lie in the depth to which the interventions were culturally adapted. To illustrate this concept, Resnicow *et al*[@R41] contrasted surface and deep structural cultural adaptations. Surface structure is based on superficial characteristics of a population including people, language, places and food. Conversely, deep structure involves the integration of the sociocultural concepts, historical context and psychological factors unique to a population. Resnicow *et al*[@R41] states "while adding surface structure to health programming may increase the receptivity of messages, it is deep cultural adaptation that truly fosters salient messaging". In turn, it is possible that the trials from the meta-analysis achieved a greater depth of cultural adaptation compared with the RCTs conducted in Europe and described in this review.

There are several possible explanations underlying the differences in HbA1c changes reported in trials conducted in India compared with trials of patients living in Europe. While the UK studies were larger and mainly adopted an RCT design, the studies in India were generally smaller and eight of the studies employed a pre-post study design (usually a single group) that limits the ability to ascertain causality with the interventions and are associated with some overinflation of effect estimates.[@R42] In addition, the variance in results may be explained by differences between the patient populations used in the two different regions. Specifically, trials of South Asians living in India included younger patients and more men than women. It is possible that men may have been more able to engage in physical activity programmes or exerted more control over the diet at home than women. Another possible explanation arises from systemic differences between the two regions. While the UK system is publicly funded, the Indian healthcare system has both private and public funding. Considering privatisation and different levels of socioeconomic position between the regions, there may be significantly less baseline knowledge of diabetes among patients living in India allowing for greater gains with interventions. Additional explanations regarding the differences in outcomes may be rooted in the design of the interventions used in trials. Compared with studies from India, the European studies did not include specific exercise programmes. While it is likely that diabetes self-management education featured in the Europe-based studies advised physical exercise, the trials from India formally integrated yoga and resistance training into their interventions. Studies from India also tended to incorporate experiential-based interventions including meditation training, cooking competitions and dancercise. This raises the possibility that strategies that are immersive and experiential rather than didactic/instructional may lead to better health behaviour change in South Asian groups. Moreover, while all studies from both locations delivered education, advice and training in Indian languages, it is not clear if any deeper cultural adaptations were employed; such adaptations may have been more implicit in the Indian-based interventions. For example, the UK studies featured interventions that were linguistically accessible for the patient population (ie, South Asian link workers, picture flashcards); meanwhile, however, many interventions from India ventured beyond language to include culturally rooted traditions such as specific forms of yoga, meditation and dance. Conversely, South Asian trial participants living in Europe may have been more acculturated compared with those living in India so that cultural adaptation of a diabetes education programme was less effective. Several studies identified significant social stigma attached to having diabetes in South Asian populations that might have negatively influenced their taking part in research studies or fully participating in the research interventions within trials in India and the West. Whether this stigma differs between migrant and indigenous Indians is unknown. Indeed, studies of Western trials demonstrate lower participation of South Asians in clinical studies compared with their non-South Asian counterparts.[@R43] Additionally, though all the studies from India reported some statistically significant positive outcomes, it is possible that smaller study effects/publication bias could exist here, and thus small studies from India with negative outcomes may have not been published.

There are several potential reasons underlying the significant intercountry differences in education-based trials, whereby more success in improvement of knowledge of and practices related to diabetes was observed in studies that originated from India. One possible explanation is that the educational interventions from India provided patients with a broader scope of knowledge; that is, information beyond the fundamentals of diabetes self-management. For instance, the intervention conducted by DeSouza and Subrahmanya Nairy[@R26] [@R27] taught patients about relaxation and stress management as well as the role of family support and participation. Similarly, the programme employed by Balagopal *et al*[@R19] featured education on meditation and relaxation techniques. Meanwhile, on the basis of the descriptions of UK educational studies, the UK interventions did not appear to venture into these domains. Furthermore, it is also unclear as to whether the success of trials from India assessing patient knowledge was due to something more than just education; specifically, there may exist the inherent ability of the interventions from India to encompass more cultural aspects then we realise. Overall, therefore, the strength of the educational trials from India may have been a blend of encompassing a larger breadth of educational domains and embodying a greater depth of cultural adaptation.

There are several limitations of this systematic review. In terms of the studies selected for the review, the overall quality of the studies was in the low-to-moderate range according to the quality components we studied. As such, each study is limited by potential biases. In addition, many of the studies, especially those from India, had smaller sample sizes and interventions between studies varied. Most trials did not report information on blinding of outcome assessment or details of the randomisation, thereby limiting the conclusions of this review. All of the studies conducted in South Asian countries were limited to India, and therefore these findings may not be generalised to other South Asian populations. The lack of studies from other South Asian countries may reflect differences in research support rather than a lower prevalence of diabetes in other South Asian countries. Given the significant heterogeneity in interventions and outcome results, a pooled analysis was not possible. In addition, key components of diabetes management including medication adherence were not addressed in almost all of the trials.

Conclusion {#s5}
==========

Overall, effectiveness of interventions differed by region. The most successful interventions for reducing HbA1c were more likely to be conducted among South Asians living in India and those interventions included yoga and exercise. While studies from both Western countries and South Asia observed improvements in lipid and blood pressure outcomes, studies from India more often reported reduction in patient BMI, WC and improved diabetes knowledge. Novel interventions are needed to improve glycaemic control of South Asians living in Western countries such as the inclusion of yoga or use of dance to engage participants in improving health behaviours.
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